SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-23-012978
Filing Date
2023-04-20
Accepted
2023-04-19 19:00:46
Documents
78
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 2865984
2 ex23-1.htm EX-23.1 4204
3 ex31-1.htm EX-31.1 23100
4 ex31-2.htm EX-31.2 22456
5 ex32-1.htm EX-32.1 6677
6 ex32-2.htm EX-32.2 6688
  Complete submission text file 0001493152-23-012978.txt   10827367

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE otlc-20221231.xsd EX-101.SCH 71880
8 XBRL CALCULATION FILE otlc-20221231_cal.xml EX-101.CAL 61700
9 XBRL DEFINITION FILE otlc-20221231_def.xml EX-101.DEF 378485
10 XBRL LABEL FILE otlc-20221231_lab.xml EX-101.LAB 550704
11 XBRL PRESENTATION FILE otlc-20221231_pre.xml EX-101.PRE 480569
72 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 1582106
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-21990 | Film No.: 23831050
SIC: 2834 Pharmaceutical Preparations